Trial Profile
Factors Impacting on Efficacy and Compliance to Cetuximab Treatment in First Line WT KRAS Metastatic Colorectal Cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms PREMIUM
- 21 Jan 2017 Results presented at the 2017 Gastrointestinal Cancers Symposium
- 22 Jan 2013 New trial record